According to a report by the National Radio of Canada CBC (above), a drug developed by the Montreal Clinical Research Institute in Montreal, Canada, will be tested to observe the effect on new coronary pneumonia. The main component of this drug is quercetin.
Quercetin’s English name is Quercetin, which is widely found in various plants such as onions and apples. Scientists in Canada have cooperated with the National Microbiology Laboratory of Canada a few years ago to treat diseases caused by Ebola and Seca virus with high doses of quercetin and have achieved success. Quercetin tablets produced by the Swiss pharmaceutical factory in cooperation with Canadian scientists have been certified by the US Food and Drug Administration (FDA).
Quercetin is currently an ingredient approved by Health Canada for use in dietary supplements in Canada.
Quercetin is a bioflavonoid that is essential for the absorption of vitamin C. Quercetin itself has an antioxidant function, which can reduce the damage and irritation caused by free radicals, while inhibiting the histamine reaction ). Bromelain works at the level of enzymes and proteins by limiting the effects of metabolites and neutrophils on inflammation, while also helping to increase the body’s absorption and utilization of quercetin.
This product can be used as an antioxidant to reduce the damage of free radicals to skin, tissues and organs. It can also protect blood vessel function and relieve seasonal allergy symptoms.